Spectrum Pharmaceuticals buy krebskrebs
Start price
23.08.21
/
50%
€2.01
Target price
23.08.22
€3.00
Performance (%)
-34.26%
End price
24.08.22
€1.32
Summary
This prediction ended on 24.08.22 with a price of €1.32. Massive losses of -34.26% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Spectrum Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 1.232% | 1.501% | 11.288% | 63.495% |
| iShares Nasdaq 100 | 0.695% | -1.949% | 5.586% | 88.830% |
| iShares Nikkei 225® | 2.085% | 11.061% | 31.150% | 67.951% |
| iShares S&P 500 | 0.419% | 0.215% | 4.116% | 60.991% |
Comments by krebskrebs for this prediction
In the thread Spectrum Pharmaceuticals diskutieren
In the thread Trading Spectrum Pharmaceuticals
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten